Viz.AI Funding History

Viz.ai develops AI software to coordinate care for stroke, cardiovascular and neurovascular conditions. Its stroke software was among the first AI clinical decision support tools cleared by the FDA.

Company Overview

Viz.ai

Healthcare

San Francisco, California

Official Website

Viz.AI Funding Timeline

Apr 7, 2022
Series D
US$100 million
Led by Tiger Global.
Source · viz.ai ↗
Feb 15, 2021
Series C
US$71 million
Source · viz.ai ↗
Oct 15, 2019
Series B
US$50 million
Led by Greenoaks Capital.
Source · viz.ai ↗
Jul 18, 2018
Series A
US$21 million
Led by Kleiner Perkins.
Source · viz.ai ↗

Viz.AI Founding Team

Chris Mansi
Co-founder of Viz.ai.
Status: activeReviewed: 2026-11-05
David Golan
Co-founder of Viz.ai.
Status: activeReviewed: 2026-11-05

Viz.AI Products

Viz.AI
Platform for clinical alerts and coordination of time-sensitive care.
Official Website ↗
Details and Sources
Status: activeReviewed: 2026-11-05
Sources:viz.ai